SEC Form DEFA14A filed by Halozyme Therapeutics Inc.
o | Preliminary Proxy Statement | ||||||||||
o | Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | ||||||||||
o | Definitive Proxy Statement | ||||||||||
x | Definitive Additional Materials | ||||||||||
o | Soliciting Materials Pursuant to §240.14a-12 | ||||||||||
Halozyme Therapeutics, Inc. | |||||||||||
(Name of Registrant as Specified in Its Charter) | |||||||||||
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) | |||||||||||
Payment of Filing Fee (Check the appropriate box): | |||||||||||
x | No fee required | ||||||||||
o | Fee paid previously with preliminary materials | ||||||||||
o | Fee computed on table in exhibit required by item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |